Manufacturer record
Zim Laboratories Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
16 batches manufactured by Zim Laboratories Limited (Maharashtra) were declared Not of Standard Quality between January 2019 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
16 records linked to Zim Laboratories Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| ALBENDAZOLE TABLETS I.P. 400 mg | FGT7J502Mfg 2025-09 · Exp 2028-08 | The sample does not conform to standard quality in respect of the test for "Dissolution" performed.Dissolution | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab | Nov 2025 |
| ALBENDAZOLE TABLETS I.P. 400 mg | FGT7J501Mfg 2025-09 · Exp 2028-08 | The sample does not conform to standard quality in respect of the test for "Dissolution" performed.Dissolution | State Drugs Testing Laboratory, Govt. of Tripura, Agartala. State- TripuraState lab | Nov 2025 |
| Paracetamol Tablets IP 650 mg | FDR3A101Mfg 2021-01 · Exp 2022-12 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jan 2022 |
| Paracetamol Tablets IP 650 mg. | FDR3F004Mfg 2020-06 · Exp 2022-05 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Sep 2021 |
| Diclofenac Gastro Resistant Tablets I.P. 50 mg (Regunac -50) | FZ57K801Mfg 2018-10 · Exp 2021-09 | DescriptionDescription | CDL KolkataCDSCO lab | Jan 2021 |
| Sustained Release Capsules of Ferrous Sulphate with Folic Acid (Folron Capsules) | F921K901Mfg 2019-10 · Exp 2021-09 | Assay of Folic AcidAssay | RDTL ChandigarhCDSCO lab | Jun 2020 |
| Ramizim ? 5 (Ramipril Tablets I.P. 5 mg) | EO82G801Mfg 2018-07 · Exp 2020-06 | Description, Dissolution and AssayAssay | CDL KolkataCDSCO lab | Apr 2020 |
| REGUNAC ? 50 (Diclofenac Gastro- Resistant Tablets I.P. 50 mg) | FZ57F801Mfg 2018-06 · Exp 2021-05 | DescriptionDescription | CDL KolkataCDSCO lab | Jan 2020 |
| Regunac-50 (Diclofenac Gastro Resistant Tablets I.P. 50 mg) | FZ57B801Mfg 2018-02 · Exp 2021-01 | DescriptionDescription | CDL KolkataCDSCO lab | Dec 2019 |
| Ramizim 5 (Ramipril Tablets I.P. 5 mg) | EO82M801Mfg 2018-12 · Exp 2020-11 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Nov 2019 |
| Ramizim - 2.5 (Ramipril Tablets I.P. 2.5 mg) | EH97M801Mfg 2018-12 · Exp 2020-11 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Nov 2019 |
| Regunac� - 50 (Diclofenac Gastro- Resistant Tablets I.P. 50 mg) | FZ57F801Mfg 2018-06 · Exp 2021-05 | DescriptionDescription | CDL KolkataCDSCO lab | Jul 2019 |
| Parazim 650 (Paracetamol Tablets I.P. 650 mg) | FAX8A801Mfg 2018-01 · Exp 2020-12 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2019 |
| Ramipril Tablets IP 2.5 mg (RAMIZIM- 2.5 TABLETS) | EH97F801Mfg 2018-06 · Exp 2020-05 | AssayAssay | RDTL ChandigarhCDSCO lab | May 2019 |
| Parazim-20 (Omeprazole Gastro-Resistant Capsules IP 20 mg) | FZ04B802Mfg 2018-02 · Exp 2021-01 | DissolutionDissolution | CDTL MumbaiCDSCO lab | May 2019 |
| Ramizim-5 (Ramipril Tablets I.P. 5 mg) | EO82F801Mfg 2018-06 · Exp 2020-05 | AssayAssay | CDL KolkataCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.